Edition:
United States

Bioxyne Ltd (BXN.AX)

BXN.AX on Australia Stock Exchange

0.09AUD
18 Jan 2018
Change (% chg)

$0.00 (+2.22%)
Prev Close
$0.09
Open
$0.09
Day's High
$0.09
Day's Low
$0.09
Volume
891,043
Avg. Vol
2,564,120
52-wk High
$0.14
52-wk Low
$0.01

Latest Key Developments (Source: Significant Developments)

Bioxyne posts FY loss attributable of $765,752
Wednesday, 30 Aug 2017 11:53pm EDT 

Aug 31 (Reuters) - Bioxyne Ltd :FY revenue from ordinary activities $2.1 million, up 1.5 percent.FY loss attributable $765,752 versus profit of $223,846.  Full Article

Bioxyne announces appointment of NH Chua as CEO
Monday, 12 Jun 2017 06:55pm EDT 

June 13 (Reuters) - Bioxyne Ltd :Bioxyne- announces appointment of NH Chua and maxwell parkin as directors of company.Chua, who has also been appointed chief executive officer, was vice president of Asia Pacific For New Image Limited for over 10 years.  Full Article

Bioxyne Ltd says Guy Robertson appointed CFO
Thursday, 1 Sep 2016 01:36am EDT 

Bioxyne Ltd : Appointment of Guy Robertson as chief operating officer and chief financial officer with effect from today .  Full Article

Bioxyne signs agreement with Datapharm to undertake a clinical trial
Wednesday, 22 Jun 2016 11:08pm EDT 

Bioxyne Ltd : Signed an agreement with datapharm Australia to undertake a clinical trial . Says agreement to undertake a clinical trial to support its Australian launch and marketing of progastrim® and protract .  Full Article

BRIEF-Bioxyne Launches New Zealand Dairy Formula Product In South East Asia

* LAUNCHES NEW ZEALAND DAIRY FORMULA PRODUCT IN SOUTH EAST ASIA Source text for Eikon: Further company coverage:

No consensus analysis data available.